Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Employment agrmnt
Quarterly results
CC transcript
Asset disposition

ARIAD PHARMACEUTICALS INC (ARIA) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/15/2021 4 TAKEDA PHARMACEUTICAL CO LTD (10% Owner) has filed a Form 4 on Theseus Pharmaceuticals, Inc.
Txns: Converted 1,615,427 shares @ $0
Converted 1,615,427 preferred shares @ $0
10/15/2021 3 TAKEDA PHARMACEUTICAL CO LTD (10% Owner) has filed a Form 3 on Theseus Pharmaceuticals, Inc.
04/07/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/27/2017 CT ORDER Form CT ORDER - Confidential treatment order
02/27/2017 15-12B Form 15-12B - Securities registration termination [Section 12(b)]
02/21/2017 SC 13D/A Sarissa Capital Management LP reports a 0% stake in ARIAD Pharmaceuticals, Inc.
02/16/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
02/16/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
02/16/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
02/16/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
02/16/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
02/16/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
02/16/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
02/16/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
02/16/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
02/16/2017 8-K Quarterly results
02/16/2017 4 Schlesinger Sarah J. (Director) has filed a Form 4 on ARIAD PHARMACEUTICALS INC
02/16/2017 4 CLACKSON TIMOTHY P (President, R&D, CSO) has filed a Form 4 on ARIAD PHARMACEUTICALS INC
02/16/2017 4 Haimovitz Jules (Director) has filed a Form 4 on ARIAD PHARMACEUTICALS INC
02/16/2017 4 Bickerstaff George (Director) has filed a Form 4 on ARIAD PHARMACEUTICALS INC
02/16/2017 4 Herron Jennifer Lyn (Exec V.P. Chief Comm'l Officer) has filed a Form 4 on ARIAD PHARMACEUTICALS INC
02/16/2017 4 Cole Hugh M (SVP, Chief Business Officer) has filed a Form 4 on ARIAD PHARMACEUTICALS INC
02/16/2017 4 Gansler Jayne M. (Senior V.P. Human Resources) has filed a Form 4 on ARIAD PHARMACEUTICALS INC
02/16/2017 4 RIEDEL NORBERT G (Director) has filed a Form 4 on ARIAD PHARMACEUTICALS INC
02/16/2017 4 Bollag Daniel M (Sr. VP, Reg. Affairs & Quality) has filed a Form 4 on ARIAD PHARMACEUTICALS INC
02/16/2017 4 Panayiotopoulos Paris (President and CEO) has filed a Form 4 on ARIAD PHARMACEUTICALS INC
02/16/2017 4 Protopapas Anna (Director) has filed a Form 4 on ARIAD PHARMACEUTICALS INC
02/16/2017 4 Soni Manmeet Singh (EVP, CFO & Treasurer) has filed a Form 4 on ARIAD PHARMACEUTICALS INC
02/16/2017 4 Kogan Elona Esq. (Sr. V. P. - General Counsel) has filed a Form 4 on ARIAD PHARMACEUTICALS INC
02/16/2017 4 DENNER ALEXANDER J (Director) has filed a Form 4 on ARIAD PHARMACEUTICALS INC
02/16/2017 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
02/16/2017 SC 13D/A TAKEDA PHARMACEUTICAL CO LTD reports a 100% stake in ARIAD PHARMACEUTICALS INC
02/16/2017 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
02/14/2017 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy